Showing results (111-120 of 318) with videos related to

Sort By:
Pageof 32
Hepatology (Baltimore, Md.)|January 1, 1991
Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic studyA Hadengue, R Moreau, Y Bacq, et al.
Journal of Gastroenterology and Hepatology|September 1, 1992
Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertensionA Koshy, T Sekiyama, A Hadengue, et al.
Clinical Pharmacology and Therapeutics|September 1, 1987
Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosisA Koshy, A Hadengue, S S Lee, et al.
Hepatology (Baltimore, Md.)|May 1, 1992
Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansionA Hadengue, R Moreau, C Gaudin, et al.
Thrombosis and Haemostasis|December 1, 1996
Influence of sialic acid on erythrocyte aggregation in hypercholesterolemiaA Hadengue, S M Razavian, M Del-Pino, et al.
Journal of Pharmacological Methods|November 1, 1988
Model for the study of portal-systemic collateral vascular resistance in the conscious ratA Koshy, R Cerini, D Bernuau, et al.
Journal of Hepatology|January 1, 1993
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranololD Lebrec, R Moreau, S Cailmail, et al.
Schweizerische Medizinische Wochenschrift|November 2, 1996
[Rapidly progressive ascites]A Hadengue, P Grosjean, C Genton, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Effect of the severity of liver disease on renal hemodynamics and renal oxygen consumption in patients with cirrhosis]R Moreau, A Hadengue, C Gaudin, et al.
Gastrointestinal Endoscopy|June 28, 2001
Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placeboH Nishida, E Giostra, L Spahr, et al.
Pageof 32